课题基金 / 基金详情

Role of Huntingtin in Vesicle Transport

Role of Huntingtin in Vesicle Transport
亨廷顿蛋白在囊泡运输中的作用
批准号:
6927160
负责人:
Marian DiFiglia
金额:
$62.98万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-15 至 2007-07-31

项目摘要

项目成果

Marian DiFiglia的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A polygutamine expansion in the N-terminus of huntingtin (N-hn) causes Huntington's disease (HD). There is no effective treatment for HD. Although mutant N-Fin fragments are known to accumulate in HD neurons and cause cell dysfunction in vitro, a mechanism (or mechanisms) that explains the selective loss of striatal and cortical projection neurons remains elusive. Wild type and mutant htt associate with membranes in the endocytic and secretory pathway. Our overall hypothesis is that mutant N-htt 's association with neuronal membranes contributes to early cellular dysfunction in the cytoplasm in HD. One of these membrane compartments includes the autophagosome/lysosomal system, which accumulates full-length or large N-htt fragments of mutant htt. Although htt ostensibly lacks transmembrane domains, it associates tightly with membranes. We speculate that candidate domains in the N-terminus involved in protein-protein interactions promote membrane binding. Little is known about the degradative pathways that form N-htt fragments in vivo. Identifying the sites of protease cleavage in the N-terminus of htt is important for understanding how the protein is regulated. Calpain, a calcium dependent protease, which regulates the function of many proteins involved in membrane/cytoskeleton organization, cleaves htt near its N-terminus and produces long-lived N-htt fragments that are enriched in membrane fractions in brain. We speculate that mutant N-htt products of calpain cleavage undergo a different processing from the wt fragments in neurons that leads to cellular dysfunction in HD. HD mice also show abnormal function of striatal NMDA receptors. One way that mutant Fin might cause the dysfunction of NMDA receptors is by disrupting the assembly of NMDA receptor subtypes at the cell surface. The specific aims are: 1: To understand the role of mutant htt induced autophagy in cell dysfunction, 2: To determine whether htt proteolysis by calpain contributes to HD pathogenesis and 3: To determine the effects of mutant htt on protein transport within the secretory pathway. The results of these studies will provide new insights about the mechanisms of cellular dysfunction in HD and suggest novel therapeutic targets that can reduce the potentially harmful effects of mutant N-htt fragments.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41598-018-26255-1
发表时间: 2018-05-22
期刊: Scientific reports
影响因子: 4.6
作者: [McClory H, Wang X, Sapp E, Gatune LW, Iuliano M, Wu CY, Nathwani G, Kegel-Gleason KB, DiFiglia M, Li X]
通讯作者: Li X
DOI: 10.1016/j.nbd.2009.08.003
发表时间: 2009-11
期刊: Neurobiology of disease
影响因子: 6.1
作者: [Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, Aronin N, Difiglia M]
通讯作者: Difiglia M
Huntingtin is degraded to small fragments by calpain after ischemic injury.
亨廷顿蛋白在缺血性损伤后被钙蛋白酶降解成小碎片。
DOI: 10.1016/s0014-4886(03)00132-8
发表时间: 2003
期刊: Experimental neurology
影响因子: 5.3
作者: [Kim,Manho, Roh,Jae-Kyu, Yoon,ByungWoo, Kang,Lami, Kim,YunJ, Aronin,Neil, DiFiglia,Marian]
通讯作者: DiFiglia,Marian
Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
突变型亨廷顿蛋白和糖原合酶激酶 3-β 在亨廷顿病症状前敲入小鼠模型的神经元脂筏中积聚。
DOI: 10.1002/jnr.22184
发表时间: 2010
期刊: Journal of neuroscience research
影响因子: 4.2
作者: [Valencia,Antonio, Reeves,PatrickB, Sapp,Ellen, Li,Xueyi, Alexander,Jonathan, Kegel,KimberlyB, Chase,Kathryn, Aronin,Neil, DiFiglia,Marian]
通讯作者: DiFiglia,Marian
Increase Rab11 Activity as HD Therapy
  • 批准号:
    8690180
  • 项目类别:
  • 资助金额:
    $35.76万
  • 财政年份:
    2011
  • 负责人:
    Marian DiFiglia
  • 依托单位:
Increase Rab11 Activity as HD Therapy
  • 批准号:
    8237338
  • 项目类别:
  • 资助金额:
    $36.34万
  • 财政年份:
    2011
  • 负责人:
    Marian DiFiglia
  • 依托单位:
Increase Rab11 Activity as HD Therapy
  • 批准号:
    8501038
  • 项目类别:
  • 资助金额:
    $34.86万
  • 财政年份:
    2011
  • 负责人:
    Marian DiFiglia
  • 依托单位:
Increase Rab11 Activity as HD Therapy
  • 批准号:
    8338826
  • 项目类别:
  • 资助金额:
    $36.17万
  • 财政年份:
    2011
  • 负责人:
    Marian DiFiglia
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究